KMT2A‐rearrangements are found in approximately 10% of all human acute leukemias (both AML and ALL), while being particularly frequent in infant (age <1 year) acute leukemias (>70%).34 This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.